All companies
Visit website
Revero
OperatingRevero Inc
Healthcare · Technology · Founded 2019
Reversing autoimmune and other chronic diseases by addressing the root causes
Valuation cap ⓘ
$30.0M
As of Apr 2022 · from Revero Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$4,275,768
Across 2 rounds since 2022
Financials
FY2019–FY2025 · from SEC filings · hover any figure for its source$39K
$37K
2019
$590K
$338K
2020
$567K
$68K
2021
$529K
−$405K
2022
$409K
$2.1M
2023
$505K
$251K
2024
$1.0M
$2.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$39,260
$589,658
$567,347
$529,087
$408,661
$504,503
$1,040,267
Cost of goods sold
$540
$12,301
$16,822
$29,975
$65,684
$137,468
$822,423
Gross margin
99%
98%
97%
94%
84%
73%
21%
Net income
$37,217
$338,410
$67,713
-$405,131
$2,062,404
$250,643
$2,124,414
Taxes paid
$0
$0
$96,520
$21,613
$0
$800
$6,040
Balance sheet
Cash
$37,297
$441,519
$479,048
$4,910,541
$2,936,450
$2,624,576
$2,278,956
Accounts receivable
$0
$0
$0
$0
$0
$0
$0
Total assets
$37,297
$446,730
$519,433
$5,001,845
$3,047,680
$2,697,732
$2,330,997
Short-term debt
$0
$71,024
$4,241
$11,902
$104,905
$118,198
$136,403
Long-term debt
$0
$0
$0
$4,879,882
$1,003,590
$890,992
$8,057,476
Total liabilities
$0
$71,024
$4,241
$4,891,784
$1,108,495
$1,009,190
$8,193,879
Other
Headcount
—
2
3
5
—
5
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$30.0M
Valuation cap
Revero Crowd SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $1.3M / $1.5MInvestors 844
Raised $3M / $3MInvestors 3,074Valuation cap $30M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 5 annual reports (FY2021–FY2025)
3,074 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001878261
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.